Please enable JavaScript to continue using this application.

Compare $CGON vs $IOVA | Chartloom

Compare

$CGON vs $IOVA

CG Oncology Inc · Iovance Biotherapeutics Inc

CGON

CG Oncology Inc

IOVA

Iovance Biotherapeutics Inc

Compare $CGON vs $IOVA

Comparing CG Oncology Inc and Iovance Biotherapeutics Inc

CGONCG Oncology Inc

IOVAIovance Biotherapeutics Inc

CGONCG Oncology Inc

Market cap

$5.63B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

135.78x

Rev growth (TTM)

1030.3%

YTD performance

52.7%

52W performance

56.8%

FCF yield

-3.2%

IOVAIovance Biotherapeutics Inc

Market cap

$6.53B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

12.69x

Rev growth (TTM)

34.5%

YTD performance

480.2%

52W performance

544.1%

FCF yield

-4.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CGON

IOVA

Detailed metrics comparison

CGON

CG Oncology Inc

IOVA

Iovance Biotherapeutics Inc

Market Cap

CGON$5.63B

IOVA$6.53B

Enterprise Value

CGON$5.61B

IOVA$6.42B

Price

CGON$63.82

IOVA$14.62

P/E Ratio

CGONN/A

IOVAN/A

P/S Ratio

CGON903.81x

IOVA20.09x

EV/Sales

CGON901.14x

IOVA19.75x

EV/EBITDA

CGON0.00x

IOVA0.00x

P/B Ratio

CGON5.80x

IOVA8.75x

P/FCF Ratio

CGONN/A

IOVAN/A

EV/FCF

CGON-31.29x

IOVA-21.65x

PEG Ratio

CGONN/A

IOVAN/A

Forward P/E (NTM)

CGONN/A

IOVAN/A

Forward P/S (NTM)

CGON135.78x

IOVA12.69x

Revenue (TTM)

CGON$6M

IOVA$325M

Revenue Growth (YoY)

CGON1030.3%

IOVA34.5%

Forward Rev Growth

CGON1916.0%

IOVA39.2%

Gross Margin (TTM)

CGON-85.2%

IOVA48.4%

Operating Margin (TTM)

CGON0.0%

IOVA0.0%

EBITDA Margin (TTM)

CGON-4008.7%

IOVA-79.8%

Net Margin (TTM)

CGON-3602.7%

IOVA-89.1%

FCF Margin (TTM)

CGON-2879.6%

IOVA-91.2%

Net Income (TTM)

CGON$-224M

IOVA$-290M

FCF (TTM)

CGON$-179M

IOVA$-296M

EPS (TTM)

CGON-$2.54

IOVA-$0.64

ROE (TTM)

CGON-2520.0%

IOVA-4051.0%

ROA (TTM)

CGON-2398.0%

IOVA-3165.0%

ROIC (TTM)

CGON-2512.0%

IOVA-4047.0%

Cash

CGON$20M

IOVA$111M

Debt

CGON$3M

IOVA$0

Net Cash/Debt

CGON$17M

IOVA$111M

Current Ratio (TTM)

CGON22.22x

IOVA4.35x

Quick Ratio (TTM)

CGON21.78x

IOVA3.74x

Debt/Equity (TTM)

CGON0.00x

IOVA0.00x

Debt/Assets (TTM)

CGON0.0%

IOVA0.0%

Interest Coverage (TTM)

CGONN/A

IOVAN/A

Net Debt/EBITDA (TTM)

CGON0.00x

IOVA0.00x

Beta

CGON0.25

IOVA0.76

52W Performance

CGON56.8%

IOVA544.1%

YTD Performance

CGON52.7%

IOVA480.2%

% from 52W High

CGON-21.2%

IOVA-4.4%

% from 52W Low

CGON78.3%

IOVA730.7%

Asset Turnover (TTM)

CGON0.01x

IOVA0.36x

FCF Yield (TTM)

CGON-3.2%

IOVA-4.5%

Earnings Yield (TTM)

CGON-4.0%

IOVA-4.4%

Dividend Yield (TTM)

CGONN/A

IOVAN/A

Rule of 40

CGON-1,849.3

IOVA-56.7

EV/GP/RG

CGONN/A

IOVA0.68

Ticker research

View CGON research View IOVA research

Metric	CGON CG Oncology Inc	IOVA Iovance Biotherapeutics Inc
Market & Valuation
Market Cap	$5.63B	$6.53B
Enterprise Value	$5.61B	$6.42B
Price	$63.82	$14.62
P/E Ratio	N/A	N/A
P/S Ratio	903.81x	20.09x
EV/Sales	901.14x	19.75x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.80x	8.75x
P/FCF Ratio	N/A	N/A
EV/FCF	-31.29x	-21.65x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	135.78x	12.69x
Revenue & Growth
Revenue (TTM)	$6M	$325M
Revenue Growth (YoY)	1030.3%	34.5%
Forward Rev Growth	1916.0%	39.2%
Profitability
Gross Margin (TTM)	-85.2%	48.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-4008.7%	-79.8%
Net Margin (TTM)	-3602.7%	-89.1%
FCF Margin (TTM)	-2879.6%	-91.2%
Net Income (TTM)	$-224M	$-290M
FCF (TTM)	$-179M	$-296M
EPS (TTM)	-$2.54	-$0.64
ROE (TTM)	-2520.0%	-4051.0%
ROA (TTM)	-2398.0%	-3165.0%
ROIC (TTM)	-2512.0%	-4047.0%
Financial Health
Cash	$20M	$111M
Debt	$3M	$0
Net Cash/Debt	$17M	$111M
Current Ratio (TTM)	22.22x	4.35x
Quick Ratio (TTM)	21.78x	3.74x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.25	0.76
52W Performance	56.8%	544.1%
YTD Performance	52.7%	480.2%
% from 52W High	-21.2%	-4.4%
% from 52W Low	78.3%	730.7%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.36x
FCF Yield (TTM)	-3.2%	-4.5%
Earnings Yield (TTM)	-4.0%	-4.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,849.3	-56.7
EV/GP/RG	N/A	0.68
Ticker research	View CGON research	View IOVA research

Valuation

P/S Ratio

IOVA

20.09x

CGON

903.81x

EV/FCF

CGON

-31.29x

IOVA

-21.65x

Growth & revenue

Revenue Growth TTM

CGON

1030.3%

IOVA

34.5%

Forward Revenue Growth

CGON

1916.0%

IOVA

39.2%

Profitability & performance

Gross Margin

IOVA

48.4%

CGON

-85.2%

ROE

CGON

-2520.0%

IOVA

-4051.0%

FCF Yield %

CGON

-3.2%

IOVA

-4.5%

52-Week Performance

IOVA

544.1%

CGON

56.8%

Detailed metrics comparison

CGON

CG Oncology Inc

IOVA

Iovance Biotherapeutics Inc

Market Cap

CGON$5.63B

IOVA$6.53B

Enterprise Value

CGON$5.61B

IOVA$6.42B

Price

CGON$63.82

IOVA$14.62

P/E Ratio

CGONN/A

IOVAN/A

P/S Ratio

CGON903.81x

IOVA20.09x

EV/Sales

CGON901.14x

IOVA19.75x

EV/EBITDA

CGON0.00x

IOVA0.00x

P/B Ratio

CGON5.80x

IOVA8.75x

P/FCF Ratio

CGONN/A

IOVAN/A

EV/FCF

CGON-31.29x

IOVA-21.65x

PEG Ratio

CGONN/A

IOVAN/A

Forward P/E (NTM)

CGONN/A

IOVAN/A

Forward P/S (NTM)

CGON135.78x

IOVA12.69x

Revenue (TTM)

CGON$6M

IOVA$325M

Revenue Growth (YoY)

CGON1030.3%

IOVA34.5%

Forward Rev Growth

CGON1916.0%

IOVA39.2%

Gross Margin (TTM)

CGON-85.2%

IOVA48.4%

Operating Margin (TTM)

CGON0.0%

IOVA0.0%

EBITDA Margin (TTM)

CGON-4008.7%

IOVA-79.8%

Net Margin (TTM)

CGON-3602.7%

IOVA-89.1%

FCF Margin (TTM)

CGON-2879.6%

IOVA-91.2%

Net Income (TTM)

CGON$-224M

IOVA$-290M

FCF (TTM)

CGON$-179M

IOVA$-296M

EPS (TTM)

CGON-$2.54

IOVA-$0.64

ROE (TTM)

CGON-2520.0%

IOVA-4051.0%

ROA (TTM)

CGON-2398.0%

IOVA-3165.0%

ROIC (TTM)

CGON-2512.0%

IOVA-4047.0%

Cash

CGON$20M

IOVA$111M

Debt

CGON$3M

IOVA$0

Net Cash/Debt

CGON$17M

IOVA$111M

Current Ratio (TTM)

CGON22.22x

IOVA4.35x

Quick Ratio (TTM)

CGON21.78x

IOVA3.74x

Debt/Equity (TTM)

CGON0.00x

IOVA0.00x

Debt/Assets (TTM)

CGON0.0%

IOVA0.0%

Interest Coverage (TTM)

CGONN/A

IOVAN/A

Net Debt/EBITDA (TTM)

CGON0.00x

IOVA0.00x

Beta

CGON0.25

IOVA0.76

52W Performance

CGON56.8%

IOVA544.1%

YTD Performance

CGON52.7%

IOVA480.2%

% from 52W High

CGON-21.2%

IOVA-4.4%

% from 52W Low

CGON78.3%

IOVA730.7%

Asset Turnover (TTM)

CGON0.01x

IOVA0.36x

FCF Yield (TTM)

CGON-3.2%

IOVA-4.5%

Earnings Yield (TTM)

CGON-4.0%

IOVA-4.4%

Dividend Yield (TTM)

CGONN/A

IOVAN/A

Rule of 40

CGON-1,849.3

IOVA-56.7

EV/GP/RG

CGONN/A

IOVA0.68

Ticker research

View CGON research View IOVA research

Metric	CGON CG Oncology Inc	IOVA Iovance Biotherapeutics Inc
Market & Valuation
Market Cap	$5.63B	$6.53B
Enterprise Value	$5.61B	$6.42B
Price	$63.82	$14.62
P/E Ratio	N/A	N/A
P/S Ratio	903.81x	20.09x
EV/Sales	901.14x	19.75x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.80x	8.75x
P/FCF Ratio	N/A	N/A
EV/FCF	-31.29x	-21.65x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	135.78x	12.69x
Revenue & Growth
Revenue (TTM)	$6M	$325M
Revenue Growth (YoY)	1030.3%	34.5%
Forward Rev Growth	1916.0%	39.2%
Profitability
Gross Margin (TTM)	-85.2%	48.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-4008.7%	-79.8%
Net Margin (TTM)	-3602.7%	-89.1%
FCF Margin (TTM)	-2879.6%	-91.2%
Net Income (TTM)	$-224M	$-290M
FCF (TTM)	$-179M	$-296M
EPS (TTM)	-$2.54	-$0.64
ROE (TTM)	-2520.0%	-4051.0%
ROA (TTM)	-2398.0%	-3165.0%
ROIC (TTM)	-2512.0%	-4047.0%
Financial Health
Cash	$20M	$111M
Debt	$3M	$0
Net Cash/Debt	$17M	$111M
Current Ratio (TTM)	22.22x	4.35x
Quick Ratio (TTM)	21.78x	3.74x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.25	0.76
52W Performance	56.8%	544.1%
YTD Performance	52.7%	480.2%
% from 52W High	-21.2%	-4.4%
% from 52W Low	78.3%	730.7%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.36x
FCF Yield (TTM)	-3.2%	-4.5%
Earnings Yield (TTM)	-4.0%	-4.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,849.3	-56.7
EV/GP/RG	N/A	0.68
Ticker research	View CGON research	View IOVA research